Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
出版年份 2019 全文链接
标题
Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-07-30
DOI
10.1111/jcmm.14538
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
- (2018) Shavira Narrandes et al. BMC CANCER
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
- (2018) Huafeng Pan et al. World Journal of Surgical Oncology
- Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
- (2018) Yuqian Liao et al. Cancer Management and Research
- Recent advances in breast cancer research impacting clinical diagnostic practice
- (2018) Amy E McCart Reed et al. JOURNAL OF PATHOLOGY
- Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
- (2018) Khyati N. Shah et al. NATURE MEDICINE
- Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
- (2017) Sofia M.E. Weiler et al. GASTROENTEROLOGY
- FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
- (2017) N Yang et al. ONCOGENE
- Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells
- (2017) Mateusz Opyrchal et al. Oncotarget
- Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis
- (2017) M Kamran et al. Oncogenesis
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
- (2017) Anastasia A. Ionkina et al. Frontiers in Oncology
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
- (2016) Min Yan et al. MEDICINAL RESEARCH REVIEWS
- Combination of Eribulin and Aurora A Inhibitor MLN8237 Prevents Metastatic Colonization and Induces Cytotoxic Autophagy in Breast Cancer
- (2016) V. K. Kozyreva et al. MOLECULAR CANCER THERAPEUTICS
- Aurora A kinase activates YAP signaling in triple-negative breast cancer
- (2016) S-S Chang et al. ONCOGENE
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Translational Exposure-Efficacy Modeling to Optimize the Dose and Schedule of Taxanes Combined with the Investigational Aurora A Kinase Inhibitor MLN8237 (Alisertib)
- (2014) J. J. Huck et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Small Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor-Initiating Cells and Overcomes Drug Resistance
- (2014) F.-M. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- FOX(M1) News--It Is Cancer
- (2013) M. Halasi et al. MOLECULAR CANCER THERAPEUTICS
- AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models
- (2013) Tammy L. Bush et al. MOLECULAR CANCER THERAPEUTICS
- Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
- (2013) X Q Zheng et al. ONCOGENE
- Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
- (2013) Jie Xu et al. PLoS One
- The TNF-α/ROS/HIF-1-induced Upregulation of FoxMI Expression Promotes HCC Proliferation and Resistance to Apoptosis
- (2012) Limin Xia et al. CARCINOGENESIS
- Breast cancer molecular subtypes – Modern therapeutic concepts for targeted therapy of a heterogeneous entity
- (2012) Cornelia Liedtke et al. MATURITAS
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- Nucleophosmin Interacts with FOXM1 and Modulates the Level and Localization of FOXM1 in Human Cancer Cells
- (2011) Uppoor G. Bhat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
- (2011) J. Millour et al. MOLECULAR CANCER THERAPEUTICS
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Treatment options for patients with triple-negative breast cancer
- (2010) Rafael Santana-Davila et al. Journal of Hematology & Oncology
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Anaphase-Promoting Complex/Cyclosome-Cdh1-Mediated Proteolysis of the Forkhead Box M1 Transcription Factor Is Critical for Regulated Entry into S Phase
- (2008) H. J. Park et al. MOLECULAR AND CELLULAR BIOLOGY
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More